What Is PANS Syndrome? Symptoms, Causes & Treatment

PANS (Pediatric Acute-onset Neuropsychiatric Syndrome) is a condition in which a child suddenly develops severe obsessive-compulsive symptoms or dramatically restricts their eating, alongside other psychiatric and physical changes. The onset is abrupt, often described by parents as overnight, and typically appears between age 3 and puberty. Unlike many psychiatric conditions that develop gradually, PANS is thought to result from an immune system attack on the brain, often triggered by an infection.

How PANS Is Defined

PANS is diagnosed based on three criteria established by the PANS Research Consortium. First, a child must have an abrupt, dramatic onset of obsessive-compulsive disorder or severely restricted food intake. Second, at least two additional neuropsychiatric symptoms must appear at the same time, drawn from seven categories: anxiety, emotional swings or depression, irritability or aggression, behavioral regression (acting much younger than their age), a drop in school performance tied to attention or memory problems, sensory or motor abnormalities, and physical signs like sleep disturbances or new bedwetting. Third, no other known neurological or medical condition can better explain the symptoms.

That last point is important. PANS is a diagnosis of exclusion, meaning doctors must rule out other medical explanations before assigning it. The exact prevalence is unknown. Population-based data simply don’t exist yet, partly because the condition’s definition is still relatively new and diagnostic awareness varies widely among clinicians.

What Happens in the Brain

The leading theory is that an infection or other immune trigger causes the body’s immune system to mistakenly attack healthy brain tissue. Brain imaging research from Stanford Medicine found that children with PANS showed signs of inflammation or swelling in deep brain structures, specifically the thalamus, basal ganglia, and amygdala. The basal ganglia help control movement, habits, cognition, and emotion, which maps neatly onto the range of symptoms children experience. About half the children with PANS in that study had subtle neurological problems detectable on a physical exam, many of them pointing to basal ganglia dysfunction.

This isn’t the same as a brain infection. The infection itself may be elsewhere in the body. The problem is the immune response it sets off, which then crosses into the brain and causes inflammation in structures that govern behavior and emotion.

PANS vs. PANDAS

PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) is a subtype of PANS. The distinction is straightforward: PANDAS is specifically linked to strep infections like strep throat or scarlet fever. PANS is the broader category, encompassing cases triggered by various infections, immune system dysfunction, or environmental factors where strep isn’t necessarily the cause. If a child meets PANS criteria and the trigger is confirmed as strep, they also meet criteria for PANDAS.

What Symptoms Look Like in Daily Life

The hallmark of PANS is speed. Parents commonly describe a child who was functioning normally one week and then, seemingly out of nowhere, develops intense fears, rituals, or refusal to eat. The OCD symptoms can be severe, consuming hours of the child’s day with intrusive thoughts and compulsive behaviors that weren’t present before.

The accompanying symptoms are equally disruptive. Children may have explosive tantrums or aggression that’s completely out of character. They may regress to behaviors they outgrew years earlier, like baby talk or clinging to a parent. Handwriting may deteriorate. Schoolwork suffers because concentration and memory are affected. Physical symptoms frequently accompany the psychiatric ones: new bedwetting in a child who was fully toilet trained, increased urinary frequency, difficulty sleeping, or heightened sensitivity to sounds, textures, or light.

What makes this especially confusing for families is how sudden and total the change can be. A child who was easygoing and socially engaged may become anxious, defiant, and unable to function at school within days.

How Doctors Test for PANS

There is no single blood test that confirms PANS. Instead, the diagnostic process combines clinical observation with lab work aimed at identifying triggers and ruling out other conditions. Initial testing typically includes a rapid strep test and throat culture. If those come back negative, doctors check for antibodies that indicate a recent strep infection (ASO and Anti-DNase B titers). A complete blood count helps screen for other infections, and a urinalysis can rule out urinary tract infections when a child has new urinary symptoms.

Depending on how severe or unusual the presentation is, additional workups may include immunoglobulin levels to assess immune function, antinuclear antibody testing to screen for autoimmune conditions, an ENT referral to evaluate the tonsils and adenoids, or swallowing studies for children who have stopped eating due to fears of choking or vomiting. A perianal strep swab may also be checked, since strep can colonize areas other than the throat.

Treatment Approaches

Treatment for PANS generally follows a layered strategy that addresses the infection, the immune response, and the psychiatric symptoms simultaneously.

If an active infection is identified, the first step is treating it. For strep-related cases, antibiotics are the standard initial approach. Children with PANDAS who have severe symptoms or repeated flare-ups may be placed on ongoing antibiotic prophylaxis to prevent future strep infections from retriggering the cycle.

Psychiatric symptoms, particularly OCD, are treated with cognitive-behavioral therapy (CBT). A pilot trial of children with PANS who hadn’t fully responded to antibiotics alone found that adding CBT reduced OCD severity by about 50%. Standard anti-anxiety medications can also be used, though children with PANS may be more sensitive to activation side effects from these drugs, so clinicians often start at lower doses.

For children who remain significantly impaired after antibiotics and psychiatric treatment, immune-targeted therapies may be considered. These can include corticosteroids or intravenous immunoglobulin (IVIg), which works by modulating the immune system to reduce the attack on the brain. Australian clinical guidelines, for instance, require that a child score at a certain severity threshold and have failed antibiotic treatment before IVIg is approved. The evidence for IVIg is still mixed. A recent randomized controlled trial failed to show that IVIg was clearly superior to placebo, so it remains an option primarily for severe, treatment-resistant cases rather than a first-line therapy.

Recovery and Long-Term Outlook

Most children with PANS improve with appropriate treatment. Some of the original patients identified by the National Institutes of Health are now healthy adults. Others have remained symptom-free but need prompt antibiotic treatment whenever they’re exposed to strep or certain other infections, because re-exposure can trigger a flare.

The pattern for many children is relapsing-remitting: symptoms improve, sometimes dramatically, and then return if a new immune trigger occurs. Over time, with consistent management of infections and immune flare-ups, many children see the episodes become less frequent and less severe. For a smaller number of children, the condition may evolve into a chronic autoimmune process requiring longer-term immune-directed treatment. No long-term outcome studies exist yet, so much of what’s known about prognosis comes from clinical experience and case tracking rather than large-scale data.

The gap between symptom onset and diagnosis remains one of the biggest challenges families face. Because the symptoms look psychiatric on the surface, children are frequently treated for OCD, anxiety, or behavioral disorders without anyone investigating an immune or infectious cause. Families who notice a sudden, dramatic personality change in their child, especially following an illness, benefit from seeking evaluation from a clinician familiar with PANS specifically.